Corteva's Corporate Governance Faces Fresh Questions Amid Fraudulent Transfer Litigation

Introduction

Corteva's corporate governance is facing renewed scrutiny as California expands litigation alleging that companies connected to the former DuPont structure used corporate restructuring and asset transfers to limit exposure to PFAS-related liabilities.

On August 6, 2026, California Attorney General Rob Bonta filed a Second Amended Complaint naming New DuPont, Corteva, Chemours, and Qnity Electronics. The filing alleges that a series of transactions, including agreements involving PFAS liabilities and insurance rights, constituted fraudulent transfers designed to place assets beyond the reach of potential creditors. These claims remain allegations and have not been established as court findings.

For Corteva, the case raises questions not only about environmental liabilities but also about how corporate governance frameworks manage historical obligations following complex spin-offs and business separations.

Corporate Restructuring Is at the Center of the Dispute

The litigation focuses on the evolution of the former DuPont corporate structure.

Chemours was separated from Old DuPont in 2015, followed by the DowDuPont transaction and subsequent separation of the agriculture business into Corteva. These transactions created several independent companies with different business portfolios and contractual arrangements governing historical liabilities.

California now alleges that the restructuring should be viewed as a continuing series of transactions rather than as isolated corporate events.

According to the state's complaint, an agreement was designed to place the majority of PFAS liabilities on Chemours while limiting the exposure of Corteva, New DuPont, and Qnity.

Governance Questions Go Beyond PFAS

The central governance issue is whether corporate restructuring can adequately separate operating businesses from legacy liabilities.

From a governance perspective, boards and management teams must consider more than the immediate commercial rationale for a transaction. They must also assess whether the allocation of assets, liabilities, insurance rights, and financial resources creates future legal or creditor risks.

This becomes particularly important when liabilities are difficult to quantify. Environmental claims can emerge years after manufacturing activities occurred, making it challenging to determine the appropriate level of financial protection at the time of a corporate separation.

Insurance Rights Become a Governance Issue

A particularly important element of the latest litigation involves PFAS-related insurance proceeds.

California alleges that in 2025, Chemours transferred its rights to certain PFAS-related insurance proceeds to Corteva and New DuPont in exchange for a lump-sum payment that the state says was less than half the estimated value of those proceeds.

Under the arrangement described by California, Chemours would retain a 50% share of further insurance recoveries after Corteva and New DuPont recovered the initial payment and an associated fee.

The dispute illustrates why insurance assets can become significant corporate-governance considerations when companies are reorganized around large contingent liabilities.

Liability Allocation Requires Board-Level Oversight

Corporate boards overseeing major restructurings must typically evaluate how liabilities will affect the financial sustainability of each resulting entity.

This can involve assessing:

• Historical environmental obligations

• Litigation exposure

• Indemnification arrangements

• Insurance coverage

• Asset transfers

• Intercompany agreements

• Capitalization of successor companies

• Contingent liabilities

The California allegations place these issues directly into the litigation spotlight.

The outcome could reinforce the importance of demonstrating that restructuring decisions were supported by documented commercial reasoning and appropriate consideration of creditor and liability interests.

Corteva's Current Business Remains Distinct

Corteva operates today as a focused agricultural company with businesses spanning seeds and crop protection. Its current commercial operations are therefore distinct from the historical PFAS-related activities at the center of the California litigation.

However, corporate separation does not necessarily eliminate contractual or legal connections to predecessor entities.

Corteva has previously entered into arrangements concerning legacy PFAS costs. Its New Jersey settlement with DuPont and Chemours, for example, allocates a portion of an $875 million settlement among the companies over a 25-year period. Corteva's stated share is 14.5%, or approximately $72 million on a present-value basis under the settlement framework.

Financial Transparency Becomes More Important

The litigation also highlights the importance of transparency around contingent liabilities.

Investors assessing a company created through multiple restructurings may need to consider not only its current balance sheet and operating performance but also:

• Legacy environmental obligations

• Litigation reserves

• Indemnification agreements

• Insurance recoveries

• Settlement commitments

• Potential claims involving predecessor companies

Greater transparency can help investors distinguish between risks arising from current operations and those inherited through historical corporate structures.

Broader Implications for Corporate Governance

The case could have implications beyond Corteva and the chemical industry.

Companies in pharmaceuticals, energy, mining, manufacturing, and other industries frequently use spin-offs and portfolio separations to create focused businesses. Where substantial environmental or mass-tort liabilities exist, however, the structure of those transactions can become a major governance consideration.

The California litigation demonstrates that regulators may examine whether asset transfers and liability allocations leave sufficient resources available to address potential claims.

This could encourage boards to place greater emphasis on legacy-liability due diligence before approving major corporate transactions.

Corporate Records and Decision-Making Could Become More Important

Another potential lesson concerns documentation.

When a restructuring is later challenged, companies may need to demonstrate why particular assets and liabilities were allocated in a specific manner.

Detailed board records, financial analyses, valuation assessments, independent advice, insurance evaluations, and transaction documentation can therefore become important evidence in defending the commercial rationale behind a restructuring.

Strong governance is not simply about complying with corporate procedures; it also involves creating an auditable record showing how significant decisions were evaluated.

Potential Impact on Future Spin-Offs

The litigation could influence how companies approach future spin-offs involving businesses with significant legacy liabilities.

Future transactions may receive greater scrutiny around:

1. Adequate capitalization of liability-bearing entities

2. Independent valuation of transferred assets

3. Treatment of insurance rights

4. Environmental liability assessments

5. Indemnification arrangements

6. Creditor protections

7. Board-level oversight

8. Long-term financial sustainability

Companies may increasingly need to demonstrate that a restructuring creates genuine operational separation rather than simply relocating liabilities.

Implications for Investors and the Chemical Industry

For investors, the case reinforces the importance of examining corporate history when evaluating companies created through major restructurings.

A company can have a strong current business while still carrying financial exposure linked to predecessor entities. Corteva's agricultural operations illustrate this distinction: its modern business is focused on agriculture, while certain legal and financial obligations originate from the historical DuPont structure.

For the wider chemical industry, the dispute demonstrates that environmental liabilities can become governance issues long after the underlying manufacturing activities have changed.

Looking Ahead

The California litigation remains unresolved, and the allegations will need to be tested through the legal process.

Nevertheless, the case is already drawing attention to how corporate boards manage legacy environmental liabilities during complex reorganizations. The questions surrounding asset transfers, insurance rights, liability allocation, and corporate separations could influence future restructuring strategies across heavily regulated industries.

For Corteva, the immediate challenge is to continue managing its agricultural business while addressing the legal and financial implications associated with its historical corporate relationships.

Conclusion

Corteva's corporate governance is facing fresh questions as California challenges the structure of liability and asset transfers among companies created through the former DuPont restructuring.

The allegations do not establish wrongdoing, but they highlight a broader governance principle: corporate restructuring requires careful consideration of both the businesses being separated and the liabilities that remain connected to them.

For chemical and agrochemical companies, the case underscores the importance of transparent liability allocation, strong board oversight, adequate financial protections, and detailed documentation when undertaking major corporate reorganizations.

As environmental litigation continues to evolve, corporate governance will increasingly play a central role in determining how companies manage the long-term risks created by their industrial past.
:::